Filing Details

Accession Number:
0001883850-22-000096
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 16:01:36
Reporting Period:
2022-11-14
Accepted Time:
2022-11-16 16:01:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796226 J Andrew Murphy 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-14 1,360 $0.00 57,110 No 5 G Direct
Common Stock Acquisiton 2022-11-14 10,000 $179.13 67,110 No 4 M Direct
Common Stock Disposition 2022-11-14 6,280 $746.00 60,830 No 4 F Direct
Common Stock Disposition 2022-11-15 109 $718.60 60,721 No 4 S Direct
Common Stock Disposition 2022-11-15 336 $719.62 60,385 No 4 S Direct
Common Stock Disposition 2022-11-15 3 $720.26 60,382 No 4 S Direct
Common Stock Disposition 2022-11-15 297 $721.74 60,085 No 4 S Direct
Common Stock Disposition 2022-11-15 272 $722.36 59,813 No 4 S Direct
Common Stock Disposition 2022-11-15 57 $723.19 59,756 No 4 S Direct
Common Stock Disposition 2022-11-15 222 $726.48 59,534 No 4 S Direct
Common Stock Disposition 2022-11-15 333 $727.17 59,201 No 4 S Direct
Common Stock Disposition 2022-11-15 361 $728.44 58,840 No 4 S Direct
Common Stock Disposition 2022-11-15 521 $729.37 58,319 No 4 S Direct
Common Stock Disposition 2022-11-15 315 $730.57 58,004 No 4 S Direct
Common Stock Disposition 2022-11-15 532 $731.49 57,472 No 4 S Direct
Common Stock Disposition 2022-11-15 78 $732.40 57,394 No 4 S Direct
Common Stock Disposition 2022-11-15 21 $733.42 57,373 No 4 S Direct
Common Stock Disposition 2022-11-15 64 $734.59 57,309 No 4 S Direct
Common Stock Disposition 2022-11-15 2 $736.40 57,307 No 4 S Direct
Common Stock Disposition 2022-11-15 66 $741.61 57,241 No 4 S Direct
Common Stock Disposition 2022-11-15 21 $742.25 57,220 No 4 S Direct
Common Stock Disposition 2022-11-15 100 $744.01 57,120 No 4 S Direct
Common Stock Disposition 2022-11-15 10 $749.92 57,110 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2022-11-14 10,000 $0.00 10,000 $179.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,290 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 109 shares of Company stock on November 15, 2022 at prices ranging from $718.44 to $718.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  3. Represents volume-weighted average price of sales of 336 shares of Company stock on November 15, 2022 at prices ranging from $719.24 to $719.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  4. Represents volume-weighted average price of sales of 297 shares of Company stock on November 15, 2022 at prices ranging from $721.05 to $721.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  5. Represents volume-weighted average price of sales of 272 shares of Company stock on November 15, 2022 at prices ranging from $722.26 to $722.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  6. Represents volume-weighted average price of sales of 57 shares of Company stock on November 15, 2022 at prices ranging from $723.13 to $723.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  7. Represents volume-weighted average price of sales of 222 shares of Company stock on November 15, 2022 at prices ranging from $726.00 to $726.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  8. Represents volume-weighted average price of sales of 333 shares of Company stock on November 15, 2022 at prices ranging from $727.02 to $727.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  9. Represents volume-weighted average price of sales of 361 shares of Company stock on November 15, 2022 at prices ranging from $728.01 to $728.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  10. Represents volume-weighted average price of sales of 521 shares of Company stock on November 15, 2022 at prices ranging from $729.01 to $729.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  11. Represents volume-weighted average price of sales of 315 shares of Company stock on November 15, 2022 at prices ranging from $730.01 to $730.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  12. Represents volume-weighted average price of sales of 532 shares of Company stock on November 15, 2022 at prices ranging from $731.03 to $731.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  13. Represents volume-weighted average price of sales of 21 shares of Company stock on November 15, 2022 at prices ranging from $733.41 to $733.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  14. Represents volume-weighted average price of sales of 66 shares of Company stock on November 15, 2022 at prices ranging from $741.61 to $741.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 15, 2022 at each separate price.
  15. The stock option award vests in four equal annual installments, commencing one year after the date of grant.